Patent details

EP2326621 Title: SUBSTITUTED 1,2,3,4- TETRAHYDROCYCLOPENTA[b]INDOL-3-YL) ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2326621
WO Application Number:
US2009004265
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP09788983.6
WO Publication Number:
WO2010011316
EPO Publication Language:
English
SPC Number:
301284
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
22/07/2009
Grant date:
08/06/2016
EP Publication Date:
01/06/2011
WO Publication Date:
28/01/2010
Claims Translations Received Date:
Claims Translation B1 Received Date:
07/09/2016
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
08/06/2016
EP B1 Publication Date:
08/06/2016
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
21/07/2029
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
22/05/2024
 
 

 

Name:
Arena Pharmaceuticals, Inc.
Address:
66 Hudson Boulevard East, 10001-2192, New York, NY, United States of America (US)

Historical Applicant/holder

From:
22/05/2024
To:
22/05/2024

 

Name:
Arena Pharmaceuticals, Inc.
Address:
235 East 42nd Street, 10017-5703, New York, NY , United States of America (US)

From:
08/06/2016
To:
22/05/2024

 

Name:
Arena Pharmaceuticals, Inc.
Address:
6154 Nancy Ridge Drive, SAN DIEGO, CA 92121, United States of America (US)

Domicile Holder

Name:
ir. M.F.J.M. Ketelaars c.s.
From:
07/09/2016
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Inventor

1

Name:
JONES, Robert M.
Address:
San Diego California 92130, United States of America (US)

2

Name:
BUZARD, Daniel J.
Address:
San Diego California 92129, United States of America (US)

3

Name:
HAN, Sangdon
Address:
San Diego California 92127, United States of America (US)

4

Name:
KIM, Sun Hee
Address:
San Diego California 92126, United States of America (US)

5

Name:
LEHMANN, Juerg
Address:
San Diego California 92129, United States of America (US)

6

Name:
ULLMAN, Brett
Address:
San Diego California 92105, United States of America (US)

7

Name:
MOODY, Jeanne V.
Address:
San Diego California 92122, United States of America (US)

8

Name:
ZHU, Xiuwen
Address:
San Diego California 92130, United States of America (US)

9

Name:
STIRN, Scott
Address:
San Diego California 92128, United States of America (US)

Priority

1

Priority Patent Number:
209374 P
Priority Date:
06/03/2009
Priority Country:
United States of America (US)

2

Priority Patent Number:
135672 P
Priority Date:
23/07/2008
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 31/403; A61P 37/00; C07D 209/70; C07D 209/88; C07D 401/12; C07D 403/12; C07D 417/12;

Publication

Bulletin

1

Bulletin Heading:
EP3
Journal edition number:
37/16
Publication date:
14/09/2016
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

2

Bulletin Heading:
EP2
Journal edition number:
23/16
Publication date:
10/06/2016
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
201623
Publication date:
08/06/2016
Description:
Grant (B1)

Deed

Change of Address

Change Kind/ Decision Type:
Owner
Deed Number:
RC202400950A
Date Registered:
22/05/2024
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
dr. R.C. van Duijvenbode c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of Address

Change Kind/ Decision Type:
Owner
Deed Number:
RC202400950B
Date Registered:
22/05/2024
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
dr. R.C. van Duijvenbode c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
31/07/2026
Annual Fee Number:
18
Annual Fee Amount:
1200 Euro
Last Annual Payment Date:
18/06/2025
Last Annual Fee Paid Number:
17
Last Annual Fee Paid Amount:
1100 Euro
Payer:
Master Data Center
Filing date Document type Document Description Number of pages File Type
12/09/2016 Outgoing Correspondence Letter no formal defects 1 PDF /5/5/5/2/6/0800062555/docs/ep09788983.6_2_81977l271.pdf
07/09/2016 Claims First filed claims 9 PDF /5/5/5/2/6/0800062555/docs/ep09788983.6_0_claims20160907143858212.pdf
07/09/2016 Incoming Correspondence Electronic Accompanying letter incoming document 2 PDF /5/5/5/2/6/0800062555/docs/ep09788983.6_1_incomingcorrespondenceelectronic20160907143901290.pdf